• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    AMAG Pharmaceuticals, Inc. (AMAG)

    -NasdaqGS
    44.17 0.87(2.01%) Dec 19, 3:59PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 25,494   24,802   20,835   21,711  
    Cost of Revenue2,968  2,743  2,837  3,326  
    Gross Profit 22,526   22,059   17,998   18,385  
    Operating Expenses
    Research Development5,358  4,540  6,498  6,581  
    Selling General and Administrative12,875  16,284  17,491  15,799  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 4,293   1,235   (5,991) (3,995)
    Income from Continuing Operations
    Total Other Income/Expenses Net294  269  365  341  
    Earnings Before Interest And Taxes4,587  1,504  (5,626)(3,654)
    Interest Expense3,129  3,051  1,476   -  
    Income Before Tax1,458  (1,547)(7,102)(3,654)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops1,458  (1,547)(7,102)(3,654)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 1,458   (1,547) (7,102) (3,654)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 1,458   (1,547) (7,102) (3,654)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.